Correlation analysis between IDH mutation and clinicopathological features in these five groups of gliomas revealed that IDH mutation was associated with a younger age at diagnosis and in patients with MGMT methylation and ATRX mutation, respectively by Pearson χ2 test, but it was not correlated with TERTp mutation (p < 0.05). The gene discussed is IDH1; the disease is central nervous system cancer.